V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005405 | 320003729 | null | 72 | Curative (C) | 2015-07-10 | 2015-07-17 | CAPECITABINE + IRINOTECAN | 02 | N | 320018305 | NIVOLUMAB |
| 320005406 | 320003730 | 1.7 | null | Curative (C) | 2017-08-15 | 2018-02-05 | VAI (Ifos 3g/m2) | N | N | 320018354 | RMS 2005 TRIAL |
| 320005407 | 320003730 | null | 48 | Palliative (P) | 2017-10-04 | 2017-10-06 | CETUXIMAB + RT | 02 | Y | 320018354 | CARBOPLATIN + RT |
| 320005408 | 320007299 | 1.73 | 74 | Adjuvant (A) | 2014-02-13 | 2014-03-08 | CNS Low Grade Glioma Vinblastine | N | null | 320018384 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005410 | 320003732 | 1.64 | 90 | Curative (C) | 2015-03-12 | 2015-06-12 | Docetaxel | N | null | 320018416 | CETUXIMAB + CISPLATIN + FU |
| 320005411 | 320003734 | 1.51 | null | Adjuvant (A) | 2014-09-16 | 2014-09-16 | Olaparib | N | null | 320018420 | CAPECITABINE + OXALIPLATIN |
| 320005412 | 320003735 | 1.7 | 64.7 | Palliative (P) | 2016-04-07 | 2016-04-30 | Gemcitabine 1000mg/m2 D1 8 15 | N | null | 320018420 | DOCETAXEL |
| 320005415 | 320003737 | 1.87 | 55.4 | null | 2017-04-18 | 2017-05-31 | IBRUTINIB | N | null | 320018500 | CARBOPLATIN + ETOPOSIDE |
| 320005416 | 320003740 | 1.69 | 81.6 | Adjuvant (A) | 2014-05-31 | 2014-06-08 | Trabectedin | N | N | 320018528 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005417 | 320006647 | 1.75 | 88 | Neo-adjuvant (N) | 2015-08-29 | 2015-09-17 | Capecitabine (14 days)+Carboplatin | N | N | 320018528 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320005418 | 320006647 | 1.76 | null | Adjuvant (A) | 2018-08-29 | 2018-09-12 | IVA | N | N | 320018528 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320005419 | 320006647 | 1.63 | 71.9 | Palliative (P) | 2016-05-08 | 2016-05-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 320018528 | IRINOTECAN + VINCRISTINE |
| 320005420 | 320003743 | 1.96 | 88.6 | Palliative (P) | 2015-03-18 | 2015-04-08 | CISPLATIN + ETOPOSIDE | 02 | N | 320018651 | ECX |
| 320005421 | 320003744 | 1.46 | 76.4 | Neo-adjuvant (N) | 2016-10-14 | 2016-11-11 | Docetaxel 75mg/m2 (21 day) | N | N | 320018655 | CARBOPLATIN + CETUXIMAB + FU |
| 320005422 | 320003745 | 1.67 | 55.6 | Palliative (P) | 2014-05-14 | 2014-05-16 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 320018677 | EMA |
| 320005423 | 320003747 | null | 56 | Adjuvant (A) | 2015-09-16 | 2015-12-14 | Cetuximab + Radiotherapy Maint | 02 | N | 320018693 | PACLITAXEL + TRASTUZUMAB |
| 320005424 | 320003748 | 1.64 | null | Curative (C) | 2015-10-05 | 2015-11-11 | Carboplatin + Cetuximab (>Cycle 2) | N | Y | 320018693 | PEMBROLIZUMAB |
| 320005425 | 320003750 | 1.8 | 57.1 | Adjuvant (A) | 2017-11-20 | 2017-11-20 | CARBOPLATIN + RT | 2 | N | 320018760 | CAPECITABINE + CISPLATIN + STREPTOZOCIN |
| 320005426 | 320005709 | 1.62 | null | Adjuvant (A) | 2017-03-29 | 2017-03-31 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320018760 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005427 | 320005710 | 1.8 | 67.5 | Palliative (P) | 2018-02-17 | 2018-02-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320018772 | CARBOPLATIN + RT |
| 320005428 | 320003753 | 1.6 | 65.1 | Neo-adjuvant (N) | 2018-07-16 | 2018-07-19 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 320018773 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005429 | 320003754 | 1.7 | 89.4 | Curative (C) | 2018-03-08 | 2018-04-09 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | Y | 320018773 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005430 | 320003755 | 1.52 | 15 | Palliative (P) | 2013-08-30 | 2013-10-19 | PEMBROLIZUMAB | N | N | 320018796 | CAPECITABINE |
| 320005431 | 320003757 | null | 28.4 | Curative (C) | 2016-07-01 | 2016-07-25 | CARBOPLATIN + ETOPOSIDE | null | Y | 320018821 | MITOMYCIN INTRAVESICULAR |
| 320005432 | 320003758 | 1.72 | null | Palliative (P) | null | 2016-10-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320018831 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 320005433 | 320003758 | 1.76 | 45 | Palliative (P) | 2017-09-30 | 2017-10-01 | Bevacizumab+Carbo+Gemcitabine | 2 | Y | 320018831 | CETUXIMAB + RT |
| 320005434 | 320003760 | 1.78 | null | Curative (C) | 2014-11-04 | 2014-11-28 | Atezolizumab | N | Y | 320018843 | MITOMYCIN INTRAVESICULAR |
| 320005435 | 320005714 | 1.57 | 77 | Palliative (P) | 2015-04-22 | 2015-05-06 | DOCETAXEL + GEMCITABINE | N | N | 320018849 | PEMBROLIZUMAB |
| 320005436 | 320005714 | 1.75 | 83.65 | Adjuvant (A) | 2012-11-30 | 2012-12-07 | IVA | 02 | N | 320018849 | METHOTREXATE |
| 320005437 | 320003761 | 1.1 | 68.2 | Palliative (P) | 2019-03-25 | 2019-03-26 | CNS LGG 2004 03 vinc weekly+ carbo | 02 | null | 320018884 | CISPLATIN + LIPOSOMAL DOXORUBICIN |
| 320005438 | 320005715 | 1.75 | 73.05 | Curative (C) | 2013-07-18 | 2013-07-28 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 320018895 | ICON8B TRIAL |
| 320005439 | 320005715 | 1.79 | null | Adjuvant (A) | 2013-09-02 | 2013-10-06 | CETUXIMAB + RT | N | N | 320018895 | TEMOZOLOMIDE |
| 320005440 | 320003762 | null | 60.3 | Adjuvant (A) | 2016-07-16 | 2016-09-07 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 320018908 | CISPLATIN + GEMCITABINE |
| 320005441 | 320003763 | 1.81 | 102 | Adjuvant (A) | 2014-01-28 | 2014-03-13 | TEMOZOLOMIDE | N | N | 320018909 | CETUXIMAB + CISPLATIN + FU |
| 320005442 | 320003764 | null | 67.5 | Adjuvant (A) | 2014-01-05 | 2014-01-05 | Capecitabine + Cisplatin | 2 | null | 320018918 | CAPECITABINE |
| 320005443 | 320003764 | 1.87 | 66 | Not known (9) | 2014-07-04 | 2014-08-04 | CARBOPLATIN + FLUOROURACIL | Y | N | 320018918 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320005444 | 320006655 | 1.68 | null | Neo-adjuvant (N) | 2014-03-11 | 2014-03-20 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320018942 | CISPLATIN + VINORELBINE |
| 320005445 | 320003766 | 1.76 | 79.7 | Adjuvant (A) | 2015-03-27 | 2015-04-01 | Olaparib | N | N | 320018943 | CETUXIMAB + RT |
| 320005446 | 320003767 | 1.77 | 84 | Palliative (P) | 2015-09-12 | 2015-09-13 | CARBOPLATIN + RT | 02 | N | 320018958 | IPILIMUMAB |
| 320005447 | 320003768 | 0 | 75.15 | null | 2017-01-07 | 2017-01-16 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 320018974 | CETUXIMAB + CISPLATIN + FU |
| 320005448 | 320005720 | 1.7 | 55.7 | Palliative (P) | 2014-05-28 | 2014-08-31 | Paclitaxel albumin (Abraxane) 21day | N | Y | 320018992 | IVA |
| 320005449 | 320005720 | 1.8 | 90 | 3 | 2015-02-17 | 2015-03-03 | VIDE | 02 | N | 320018992 | CARBOPLATIN + RT |
| 320005450 | 320003770 | 1.48 | 91 | Curative (C) | 2016-01-21 | 2016-01-21 | CISPLATIN + GEMCITABINE | 02 | Y | 320019024 | CAPECITABINE |
| 320005451 | 320003772 | 1.78 | null | Palliative (P) | 2017-11-22 | 2017-11-22 | Cisplatin+Gemcitabine (gallbladder) | 2 | N | 320019030 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320005452 | 320003773 | 1.76 | null | Palliative (P) | 2016-11-17 | 2016-12-03 | Trifluridine + Tipiracil | N | N | 320019030 | ATEZOLIZUMAB |
| 320005453 | 320003774 | 1.7 | 105.3 | Curative (C) | 2017-07-14 | 2017-08-12 | Carboplatin + Etoposide IV 3 day | N | N | 320019064 | VINBLASTINE |
| 320005454 | 320003774 | 1.75 | 53 | Curative (C) | 2013-12-09 | 2014-02-11 | CAPECITABINE + CETUXIMAB + CISPLATIN | N | N | 320019064 | CAPECITABINE + CARBOPLATIN |
| 320005455 | 320003775 | null | 69 | Palliative (P) | 2014-10-17 | 2014-10-22 | Cetuximab + Radiotherapy Maint | N | Y | 320019077 | DOCETAXEL |
| 320005456 | 320003775 | 1.78 | 63.7 | Palliative (P) | 2015-03-24 | 2015-03-25 | Carboplatin + Etoposide IV 3 day | N | N | 320019077 | LOMUSTINE + PROCARBAZINE |
| 320005457 | 320003776 | 1.76 | 27.5 | Neo-adjuvant (N) | 2017-01-07 | 2017-01-09 | Cisplatin + Paclitaxel | 2 | N | 320019104 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |